NCT04639492View on ClinicalTrials.gov

Postbiotic MBS and Metformin Combination in Patients With T2DM

NACompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

November 2, 2020

Primary Completion Date

June 30, 2022

Study Completion Date

September 23, 2022

Conditions
Type-II Diabetes
Interventions
DIETARY_SUPPLEMENT

MBS oral solution

Oral BIDAC, twice a day before breakfast and dinner times

Trial Locations (1)

106

Microbio Investigative Site, Taipei

All Listed Sponsors
lead

Microbio Co Ltd

INDUSTRY

NCT04639492 - Postbiotic MBS and Metformin Combination in Patients With T2DM | Biotech Hunter | Biotech Hunter